Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein EFR3 homolog A is a peripheral membrane protein essential for the localization and function of the PI4KA complex at the plasma membrane, which regulates the synthesis of critical signaling lipids. EFR3A’s roles include controlling cellular responses to GPCRs, organizing RAS nanoclusters for oncogenic signaling, and modulating insulin-stimulated glucose transport. Mutations and dysregulation of EFR3A have been linked to autism spectrum disorders, cancers, and cardiovascular disease, indicating a broad though currently indirect pathophysiological relevance. While pivotal in membrane lipid signaling and cellular homeostasis, EFR3A is not a direct drug target or biomarker in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein EFR3 homolog A (EFR3A).